Preeclampsia Diagnostics Market Size worth USD 1.24 Billion by 2029
The global preeclampsia diagnostics market size was valued at USD 1.03 billion in 2021 and reached USD 1.07 billion in 2022. The market is expected to reach USD 1.24 billion by 2029, exhibiting a CAGR of 2.2% during the forecast period. The rising prevalence of preeclampsia and increasing technological advancements in diagnostics procedures are expected to foster industry growth. Fortune Business Insights™ presents this information in its report titled “Preeclampsia Diagnostics Market, 2022-2029.”
Key
Industry Development
- July
2021: LifeCell Diagnostics announced a comprehensive
preeclampsia screening in India. The advanced screening detects biomarker,
sFLT-1 (soluble FMS-like tyrosine kinase-1), which enables the prediction
of the disease and helps in accurate diagnosis even in the third
trimester.
Request a Sample
Copy of the Research Report:
https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/preeclampsia-diagnostics-market-101519
Drivers and
Restraints
Development
of Innovative Preeclampsia Diagnostic Procedures to Propel Market Progress
Preeclampsia diagnostics are a set of diagnostic
procedures designed to protect mothers and infants from preeclampsia disorders.
The development of innovative preeclampsia diagnostic procedure is expected to
enhance the adoption of the diagnostic procedure. The rising prevalence of the
disorder in pregnant women across the globe is expected to enhance the
diagnostics’ adoption. For example, as per the NCBI’s research published in
July 2021, preeclampsia occurrence in France reached 8.5% among pregnant women.
These factors may drive the preeclampsia diagnostics market growth.
However, lack of awareness regarding preeclampsia is
expected to hinder the industry’s growth.
Click here to get
the short-term and long-term impact of COVID-19 on this market.
Please
visit:https://www.fortunebusinessinsights.com/industry-reports/preeclampsia-diagnostics-market-101519
COVID-19 Impact
Robust
Demand from Healthcare Sector Fostered Market Progress
This market was positively impacted during the
pandemic due to the rising demand for preeclampsia diagnostics procedures from
the healthcare sector. The increasing cases of preeclampsia led to the
procedure's rapid adoption. Further, government guidelines such as amendments
encouraging the adoption of such procedures are expected to enhance the demand
for the product. Moreover, market players experienced a huge spike in revenues
due to the procedure’s extensive adoption. For example, PerkinElmer Inc.
experienced massive growth of 31.2% during 2020, reaching USD 3,782.8 million.
These factors influenced the industry growth during the pandemic.
About Us:
Fortune Business Insights™ delivers accurate data and innovative
corporate analysis, helping organizations of all sizes make appropriate
decisions. We tailor novel solutions for our clients, assisting them to address
various challenges distinct to their businesses. Our aim is to empower them
with holistic market intelligence, providing a granular overview of the market
they are operating in.
Contact Us:
Fortune Business Insights™ Pvt. Ltd
U.S.: +1 424 253 0390
U.K.: +44 2071 939123
APAC: +91 744 740 1245
Comments
Post a Comment